Achilles Therapeutics plc (ACHL)
Mar 20, 2025 - ACHL was delisted pending liquidation
1.480
0.00 (0.00%)
Inactive · Last trade price on Mar 21, 2025

Achilles Therapeutics Analyst Ratings

Total Analysts
2
Consensus Rating
Buy
Price Target
$4.00
Upside
+170.27%

Ratings History

Analyst Firm Rating Rating Action Price Target Upside Date
Piper Sandler
Piper Sandler
Hold
Downgrades
$8$2
Hold Downgrades $8$2 +35.14% Apr 5, 2024
Chardan Capital
Chardan Capital
Strong Buy
Maintains
$11$6
Strong Buy Maintains $11$6 +305.41% Apr 5, 2024
B of A Securities
B of A Securities
Sell
Downgrades
$7$0.5
Sell Downgrades $7$0.5 -66.22% Dec 14, 2023
Chardan Capital
Chardan Capital
Strong Buy
Reiterates
$11
Strong Buy Reiterates $11 +643.24% Aug 7, 2023
Chardan Capital
Chardan Capital
Strong Buy
Maintains
$12$11
Strong Buy Maintains $12$11 +643.24% May 11, 2023
Chardan Capital
Chardan Capital
Strong Buy
Maintains
$20$17
Strong Buy Maintains $20$17 +1,048.65% Dec 7, 2022
Piper Sandler
Piper Sandler
Buy
Maintains
$10$8
Buy Maintains $10$8 +440.54% Dec 7, 2022
JP Morgan
JP Morgan
Sell
Initiates
$11
Sell Initiates $11 +643.24% Apr 26, 2021
Chardan Capital
Chardan Capital
Strong Buy
Initiates
$27
Strong Buy Initiates $27 +1,724.32% Apr 26, 2021
Piper Sandler
Piper Sandler
Buy
Initiates
$25
Buy Initiates $25 +1,589.19% Apr 26, 2021
Oppenheimer
Oppenheimer
Buy
Initiates
$23
Buy Initiates $23 +1,454.05% Apr 26, 2021